HEALIUS LIMITED — Director's Dealing 2022

Feb 23, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity HEALIUS LIMITED	Name of entity HEALIUS LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Jennifer Macdonald
Date of last notice	22 November 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	23 February 2022
No. of securities held prior to change	Jennifer Macdonald 12,048 NED Share Rights Jennifer Macdonald 35,000 Ordinary shares
Class	Fully paid Ordinary Shares
Number acquired	6,024
Number disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$30,000 cash equivalent using the volume weighted average price of Ordinary Shares over the five business days immediately following the Healius Limited Annual General Meeting on 21 October 2021, being $4.98.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change		6,024 NED Share Rights Jennifer Macdonald 6,024 Ordinary Shares Jennifer Macdonald 35,000 Ordinary shares Jennifer Macdonald _ Shares are subject to a holding lock as “Restricted Securities” _under the NED Share Plan.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back		Vesting of 50% of NED Share Rights issued in respect of FY 2022 into Ordinary Shares (restricted) under the NED Share Plan.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written N/A clearance was required? If so, was prior written clearance provided to allow the N/A trade to proceed during this period? If prior written clearance was provided, on what date was N/A this provided?

Authorised by the Company Secretary.

Charles Tilley Company Secretary Date: 24 February 2022

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011